NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
NeuroPace, Inc. (NPCE) to present at the Needham 23rd Annual Healthcare Conference. CEO Joel Becker to provide a corporate presentation on April 8. The company focuses on epilepsy treatment and will engage in investor meetings.
03/27/2024 - 04:05 PM
MOUNTAIN VIEW, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will present at the Needham 23rd Annual Healthcare Conference, taking place virtually from April 8-11.
Joel Becker, NeuroPace’s Chief Executive Officer, will provide a corporate presentation on Monday, April 8 at 3:45pm ET, and management will participate in one-on-one meetings with investors during the conference.
The presentation will be accessible via a live webcast here . A webcast replay of the presentation will be available on the Events section of NeuroPace’s Investor website at https://investors.neuropace.com/news-and-events/events .
About NeuroPace, Inc.
Investor Contact: jfeffer@lifesciadvisors.com
When will NeuroPace present at the Needham 23rd Annual Healthcare Conference?
NeuroPace will present at the Needham 23rd Annual Healthcare Conference from April 8-11.
Who will provide the corporate presentation for NeuroPace at the conference?
Joel Becker, the Chief Executive Officer of NeuroPace, will provide the corporate presentation.
What is the focus of NeuroPace, Inc.?
NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy.
Where can investors access the webcast of NeuroPace's presentation?
Investors can access the webcast of NeuroPace's presentation on the Events section of NeuroPace's Investor website at https://investors.neuropace.com/news-and-events/events.
NPCE Rankings
#119 Ranked by Stock Gains
NPCE Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
About NPCE
the rns® system is an award-winning technology developed and manufactured in silicon valley that has been recognized for its innovation. similar to a pacemaker that monitors and responds to heart rhythms, the rns system is the world's first and only medical device that can monitor and respond to brain activity. neuropace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. the company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.in addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.
